Encompass Health CORP Form 4 insider transactions

Encompass Health Director Nancy M. Schlichting received 40 restricted stock units as part of a dividend payment on January 15, 2026, increasing her direct beneficial ownership to 21,259 shares.

Encompass Health Corp. Director Terrance Williams received 28 restricted stock units on January 15, 2026, as part of a common stock dividend payment.

Encompass Health Director Edward M. Christie III increased his direct beneficial ownership of common stock through RSU awards and deferred compensation.

Encompass Health Corp. Director Christopher R. Reidy increased his beneficial ownership of common stock through RSU awards and a deferred stock investment plan.

Encompass Health Director Greg D. Carmichael received 23 restricted stock units on October 15, 2025, as part of a routine dividend payment plan.

Encompass Health Director Edward M Christie III increased his beneficial ownership of company stock and restricted stock units through a deferred compensation plan and dividend reinvestment.

Encompass Health Director Joan E. Herman acquired 73 restricted stock units following a common stock dividend payment on October 15, 2025.

Encompass Health Director Leslye G. Katz received 73 additional restricted stock units as part of a dividend payment, increasing her beneficial ownership to 47,752 shares.

Encompass Health Director Kevin J. O'Connor received 14 restricted stock units as part of a common stock dividend payment on October 15, 2025.

Encompass Health Director Christopher R. Reidy increased his direct beneficial ownership of company common stock through RSU awards and a deferred stock investment plan.

Encompass Health Corp. Director Nancy M. Schlichting acquired 33 additional restricted stock units tied to a common stock dividend payment.

Encompass Health Director Terrance Williams received 23 restricted stock units as part of a dividend payment plan.

Encompass Health's EVP and COO, Patrick W. Tuer, reported a planned sale of 1,020 shares of common stock for $123.59 per share, effective August 27, 2025, under a Rule 10b5-1 plan.

Encompass Health Corp's EVP & CFO, Douglas Coltharp, reported a transfer of shares by his spouse to a trust, a common personal financial planning move.

Encompass Health Corp. Director Christopher R. Reidy increased his beneficial ownership of company common stock through the acquisition of Restricted Stock Units and shares purchased via a deferred compensation plan.

Encompass Health Corp. Director Nancy M. Schlichting acquired 34 additional restricted stock units on July 15, 2025, as part of a dividend reinvestment program, increasing her total beneficial ownership to 21,186 units.

Encompass Health Corp. Director Kevin J. O'Connor was awarded 15 restricted stock units on July 15, 2025, as part of a dividend reinvestment program for non-employee directors.

Encompass Health Corp. Director Patricia Anne Maryland was awarded 24 additional restricted stock units (RSUs) on July 15, 2025, as part of a routine dividend reinvestment for non-employee directors.

Encompass Health Corp. Director Leslye G. Katz was credited with 74 restricted stock units (RSUs) on July 15, 2025, as part of a dividend reinvestment program.

Encompass Health Corp Director Joan E. Herman was awarded 74 restricted stock units on July 15, 2025, as part of a routine dividend reinvestment for non-employee directors.

Encompass Health Corp. Director Edward M Christie III increased his beneficial ownership of company stock through a restricted stock unit award and purchases via a deferred compensation plan.

Encompass Health Corp. Director Greg D. Carmichael was awarded 24 additional restricted stock units on July 15, 2025, as part of a dividend payment on the company's common stock.

Encompass Health Corp. Director Terrance Williams received 24 restricted stock units (RSUs) on July 15, 2025, as part of a dividend reinvestment program, increasing his beneficial ownership to 15,118 shares.

Encompass Health's CEO, Mark Tarr, exercised stock options and sold shares on May 20, 2025, resulting in adjustments to his holdings.

Edmund Fay, Sr. Vice President and Treasurer of Encompass Health Corp, reports a gift of 3,667 shares of common stock to a donor advised fund.

Elissa Joy Charbonneau, Chief Medical Officer of Encompass Health Corp, reports the sale of 4,279 shares of common stock at a price of $116.61 per share on May 6, 2025.

Director Greg D. Carmichael reports acquisition of 1,424 shares of Encompass Health Corp stock through a restricted stock unit grant.

Director Edward M. Christie III acquired 1,424 shares of Encompass Health Corp through a restricted stock unit grant on May 1, 2025.

Director Joan E. Herman reports acquiring 1,424 shares of Encompass Health Common Stock through a restricted stock unit grant.

Leslye G. Katz, a director of Encompass Health Corp, reports the acquisition of 1,424 restricted stock units on May 1, 2025, as part of the company's 2016 Omnibus Performance Incentive Plan.